focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Perhaps I should’ve gone to Specsavers, but despite following TEK & LUCY as a holder in the former, I couldn’t tell (or care frankly) what make of glasses Micah was wearing.
Net impact on Lucyd’s sales? Oooh, I’d say a figure about as round as his lenses.
Goldgirl - it’s not really about falling out or making up. The majority of people (other than “reality” TV contestants) mostly leave that sort of stuff behind as grown ups.
If you’re happy to stick to facts - rather than presenting opinions as nailed on outcomes - then I’ll be only too pleased to agree with you in future. If not, I’ll continue to call it out, so no-one risks being misled. Your call.
Notwithstanding any real/perceived S&P correlation, whether you buy, sell or hold is IMHO likely to be influenced by your timeframe more than anything.
Timing the markets consistently is notoriously hard.
I’d also question whether SMT has much correlation to any index, given its near 30% unlisted holdings. That’s kind of been its nemesis over the past 2-3 years!
Any CEO feeling the need to talk his own share up is a major red flag in my book.
I’m not saying IMM won’t go higher. As a holder, I sincerely hope it will. But that’s not because of any faith I’ve got in either Tim.
Saigonsally - I really wouldn’t ask his advice again. Look where it’s got you so far.
"Imm will multibag" & "This is the bottom" are opinions dressed up as facts.
Yorkshirehussar - you're right. I AM fun to go out with. Least, that's what all my friends tell me.
But as Pokerchips correctly pointed out after my previous post, posting personal opinion as fact - with no evidence whatsoever to back it up - is just plain out of order & needs calling out. Which I'll continue to do until GoldGirl gets the picture.
They're most certainly NOT just presented as opinions.
Why pretend things are nailed on ("Imm will multibag". "This is the bottom") when they're just your RAMPant conjecture?
Goldgirl - all your posts are RAMPant conjecture.
Yorkshirehussar - I wasn’t chastising you.
Just expressing genuine bewilderment at how anyone could believe TEK was one of the most promising AIM companies right now. Time will tell whether you’ve timed your entry perfectly, but that doesn’t make TEK any better as a company. It’s being appallingly mismanaged.
Yorkshirehussar - "This and TEK are 2 of the most promising company's on AIM at present".
You ARE kidding about TEK, right? Have you seen how its share price is doing?
Interesting - SMT has bought back into TSMC over the past few days, building a holding of approx 1% so far (£140m).
TSMC's Q1 profits exceeded expectations on "strong AI chip demand" & it expects Q2 sales to jump for the same reason:
www.reuters.com/technology/tsmc-set-report-5-rise-first-quarter-profit-strong-ai-chip-demand-2024-04-18/
Assuming Elliott's still in at 5%, I imagine we can expect further fireworks given the recent share price retracement.
Goldgirl - agreed. "Bet" is the operative word in your post.
IMM remains a gamble, though for now at least it appears sufficiently funded.
Redred1821 - that's just plain wrong I'm afraid.
Take a look at the FTSE 100, FTSE 250, Nasdaq & Dow Jones indices. They're ALL fairly close to their 1 year highs.
So collectively, the share price of the companies within these indices must also be close to their 1 year highs.
AimingHigh2021 - to be fair, it's far too early to pass judgment on Microsalt yet and its share price IS still above IPO level (albeit over 40% off the February peak).
Lucy & Bell are looking fairly shot to pieces right now though.
But I'm sure Tek did EXACTLY the right thing when structuring these IPOs, holding on to their full allocation & watching the value grow. Oh wait - something's not gone quite to plan here.
Gotmiester - the system that denotes whether a transaction was a buy or sell is notoriously unreliable. Particularly when a transaction goes through at the exact mid price between the Ask & Bid.
So as has already been suggested, best ignored altogether & concentrate instead on market cap & overall share price trajectory.
Yorkshirehussar - I'm just fine thanks.
Merely drawing attention to the fact that we're NOT nearly there with Lupuzor. Nor do we have a trial start date yet.
Things are looking more positive short term, but people still need to get their facts straight if they're to retain credibility.
Sure, but not worth reading too much into one morning's movement. If you look at performance over one month for example, SMT has outperformed PCT. Though this is equally irrelevant IMHO.
It's the long term trend that counts. For now, PCT has significantly outperformed over 5 & 10 years. So you either switch to PCT if you think this pattern will continue. Or you stick with SMT if you don't.
In any case, how would anyone - other than employees - know when the trial was about to start. It hasn't been announced.
Yorkshirehussar - then (s)he should have said so.